EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSACIG00000004266
Gene Symbol: PSMD7
1 Cross references
236 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSACIG00000024049
Gene Symbol: PSMD8
1 Cross references
213 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSACIG00000005094
Gene Symbol: PSMB11
1 Cross references
170 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSACIG00000005601
Gene Symbol: PRMT5
1 Cross references
199 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSACIG00000017260
Gene Symbol: PRKCB
2 Cross references
213 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSACIG00000009624
Gene Symbol: PRKCD
1 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSACIG00000006903
Gene Symbol: PRKCE
1 Cross references
259 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSACIG00000006292
Gene Symbol: PRKCAA
1 Cross references
212 Possible Orthologues:

Protein Kinase C, Beta A

Ensembl ID : ENSACIG00000015116
Gene Symbol: PRKCBA
1 Cross references
205 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSACIG00000022502
Gene Symbol: PRKCDA
1 Cross references
206 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSACIG00000024202
Gene Symbol: PRKCHA
1 Cross references
223 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSACIG00000003700
Gene Symbol: PRKCQ
1 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).